×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024
Yahoo Finance
Scope of presentation included trial design, rationale, and blinded baseline data on first 50 patients randomized into the Phase II study...
3 weeks ago
Cardiol Therapeutics is conducting clinical trials of its pure cannabidiol formulation, CardiolRx, to treat inflammatory ...
Proactive financial news
Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical...
3 weeks ago
Cardiol Therapeutics Advances Heart Disease Trials - TipRanks.com
Tipranks
Cardiol Therapeutics Inc. (TSE:CRDL) has released an update. Cardiol Therapeutics Inc. has presented its Phase II ARCHER trial data at the World Congress on...
2 weeks ago
Cardiol, Happy Belly, Loblaw at 52-Week Highs
Baystreet.ca
Cardiol Therapeutics Inc. (T.CRDL) hit a new 52-week high of $3.61 Tuesday. No news stories available today. Happy Belly Food Group Inc.
2 hours ago
Canaccord Genuity ups Cardiol Therapeutics shares target citing positive trial outlook By Investing.com
Investing.com
On Thursday, Cardiol Therapeutics (NASDAQ:CRDL) shares saw its price target increased by Canaccord Genuity from $6.00 to $8.00,...
2 weeks ago
Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for ...
Yahoo Finance
Topline Results Expected in Q2 2024 This is a Designated News Release.Toronto, Ontario--(Newsfile Corp. - February 21, 2024) - Cardiol...
3 months ago
Is Cardiol Therapeutics (TSE:CRDL) In A Good Position To Deliver On Growth Plans?
Simply Wall Street
We can readily understand why investors are attracted to unprofitable companies. For example, Cardiol Therapeutics...
1 month ago
Cardiol Therapeutics (TSE:CRDL) Hits New 52-Week High at $3.27
Defense World
Shares of Cardiol Therapeutics Inc. (TSE:CRDL – Get Free Report) reached a new 52-week high on Friday . The company traded as high as C$3.27...
1 week ago
CRDL Stock Earnings: Cardiol Therapeutics Meets EPS for Q1 2024
InvestorPlace
CRDL stock results show that Cardiol Therapeutics met analyst estimates for earnings per share the first quarter of 2024.
3 weeks ago
Closing Bell: Cardiol Therapeutics Inc down on Friday (CRDL)
The Globe and Mail
In today's trading, Cardiol Therapeutics Inc opened at $3.22 and closed at $2.93. prices ranged from a low of $2.92 to a high of $3.27.
2 weeks ago